Skip to content

GRAIL, Inc. GRAL Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$52.06B+6.7%
Guardant Health logo
Guardant HealthGH
-$181.07M+27.8%
Natera, Inc. logo
Natera, Inc.NTRA
$1.77B+43.1%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$416.41M+27.7%
Immunome logo
ImmunomeIMNM
$588.69M+91.7%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$216.34M+13.6%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s total equity?
GRAIL, Inc. (GRAL) reported total equity of $2.5B in Q1 2026.
How has GRAIL, Inc.'s total equity changed year-over-year?
GRAIL, Inc.'s total equity increased by 3.6% year-over-year, from $2.41B to $2.5B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.